Marijuana extract reduces seizures in patients with Lennox-Gastaut Syndrome in clinical trial.

GW Pharmaceuticals, the maker of a marijuana-based drug used to help children with rare forms of epilepsy, announced successful clinical trials of the drug Epidiolex in the treatment of Lennox-Gastaut Syndrome (LGS).

Epidiolex is made from pharmaceutical-grade cannabidiol (CBD) oil, a nonpsychoactive compound extracted from the cannabis plant.

In this randomized, double-blind, placebo-controlled Phase 3 clinical trial of the drug, Epidiolex was found to successfully reduce seizures in patients with LGS, a rare and severe form of epilepsy that develops in childhood.

Click here to read the complete article

Emily Gray Brosious ~ ~

Recent News Articles

Tuesday December 24

Feeling Down This Holiday Season? Marijuana Might Help - Cannabis News

in Culture & Arts

by Bruce Kennedy - Editor in Chief

Many people experience stress or depression this time of year and research suggest cannabis could…

2762 hits

Wednesday December 25

Al Harrington pushing the NBA to embrace marijuana - Cannabis News

in Sports

by Bruce Kennedy - Editor in Chief

Former NBA big man Al Harrington has emerged as one of the biggest supporters of…

2517 hits

Thursday December 26

Hemp cleans toxic soil and produces clean CBD flower, study finds - Cannabis News

in CBD & Hemp

by Bruce Kennedy - Editor in Chief

The heavy metals taken up by cannabis plants grown in coal mining remediation fields were…

2709 hits

Friday December 27

Illinois legal weed poses challenge for companies with zero tolerance policies - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Recreational marijuana use will be legal in Illinois in less than a week, and some…

2589 hits

Friday December 27

Marijuana On The 2020 Ballot: These States Could Vote - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

Some of these would be citizen-led voter initiatives where activists collect signatures to qualify a…

2650 hits